CRISPR-Cas9 Editing of the HBG1 and HBG2 Promoters to Treat Sickle Cell Disease
New England Journal of Medicine · 2023
DOI: 10.1056/nejmoa2215643 ↗Kurz gefasst
Klinische Studie (Phase I) in der Zeitschrift New England Journal of Medicine, 2023. Verfasst von Akshay Sharma und 21 weiteren Autor:innen. Beteiligte Einrichtung: From St. Jude Children's Research Hospital, Memphis, TN (A.S., J.S.H., Y.Z.); Memorial Sloan Kettering Cancer Center, New York (J.-J.B., M.C.); the N…. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, CRISPR-Cas Systems, Erythrocytes, Fetal Hemoglobin. Die Arbeit wurde bisher 187-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Novartis Pharmaceuticals Corporation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From St. Jude Children's Research Hospital, Memphis, TN (A.S., J.S.H., Y.Z.); Memorial Sloan Kettering Cancer Center, New York (J.-J.B., M.C.); the Novartis Institutes for BioMedical Research, Cambridge, MA (P.B., M.A.,…
ORCID-Profile: Akshay Sharma, Jaap-Jan Boelens
Förderung
- NCI NIH HHS
- Novartis Pharmaceuticals Corporation
Zitieren
APA
Sharma, A., Boelens, J. J., Cancio, M., Hankins, J. S., Bhad, P., Azizy, M., Lewandowski, A., Zhao, X., Chitnis, S., Peddinti, R., Zheng, Y., Kapoor, N., Ciceri, F., Maclachlan, T., Yang, Y., Liu, Y., Yuan, J., Naumann, U., Yu, V. W. C., …, & LaBelle, J. L. (2023). CRISPR-Cas9 Editing of the HBG1 and HBG2 Promoters to Treat Sickle Cell Disease. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2215643
Vancouver
Sharma A, Boelens JJ, Cancio M, Hankins JS, Bhad P, Azizy M, et al. CRISPR-Cas9 Editing of the HBG1 and HBG2 Promoters to Treat Sickle Cell Disease. New England Journal of Medicine. 2023. doi:10.1056/nejmoa2215643
BibTeX
@article{Sharma2023,
author = {Sharma, Akshay and Boelens, Jaap-Jan and Cancio, Maria and Hankins, Jane S and Bhad, Prafulla and Azizy, Marjohn and Lewandowski, Andrew and Zhao, Xiaojun and Chitnis, Shripad and Peddinti, Radhika and Zheng, Yan and Kapoor, Neena and Ciceri, Fabio and Maclachlan, Timothy and Yang, Yi and Liu, Yi and Yuan, Jianping and Naumann, Ulrike and Yu, Vionnie W C and Stevenson, Susan C and De Vita, Serena and LaBelle, James L},
title = {CRISPR-Cas9 Editing of the HBG1 and HBG2 Promoters to Treat Sickle Cell Disease},
journal = {New England Journal of Medicine},
year = {2023},
doi = {10.1056/nejmoa2215643}
}
EUVIMED